“Comparison Study of the Effect of Erlotinib As a Tyrosine Kinase Inhibitor on Electrolyte Levels in Type2 Diabetic and Diabetic Nephropathy”. Ibn AL-Haitham Journal For Pure and Applied Sciences, vol. 31, no. 3, Nov. 2018, pp. 63-69, https://doi.org/10.30526/31.3.2011.